Tenon Medical, INC 10-Q quarterly reports

Tenon Medical, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenue growth driven by its SI joint fusion systems, but also highlighting significant operating losses and ongoing concerns about its ability to continue as a going concern.

Tenon Medical reports increased Q3 revenue and gross profit, but ongoing net losses and significant cash burn raise going concern doubts, partially offset by recent acquisitions and a new PIPE financing.

Tenon Medical, Inc. reported a significant decline in Q2 revenue and gross profit, alongside a reduced net loss, but disclosed substantial doubt about its ability to continue as a going concern and identified material internal control weaknesses.

Tenon Medical's Q1 2025 shows a slight revenue increase but continued net losses, with the company actively pursuing additional financing.

Tenon Medical's Q3 2024 results show a decrease in revenue compared to the same period last year, alongside a reduction in operating expenses, as the company navigates a sales restructuring and reimbursement challenges.

Tenon Medical's Q2 2024 results show increased revenue and gross profit, but the company continues to operate at a loss and faces going concern uncertainty.

Tenon Medical's first quarter 2024 results show a significant increase in revenue, driven by a 42% rise in surgical procedures using their Catamaran System, despite ongoing losses and concerns about their ability to continue as a going concern.